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Abstract
Long-lived humoral immune responses depend upon the generation of memory B cells and long-
lived plasma cells during the germinal center (GC) reaction. These memory compartments,
characterized by class-switched IgG and high-affinity Abs, are the basis for successful
vaccination. We report that a new member of the plexin family of molecules, plexin-D1, controls
the GC reaction and is required for secondary humoral immune responses. Plexin-D1 was not
required for B cell maturation, marginal zone precursor development, dark and light zone
formation, Igλ+ and Igκ+ B cell skewing, B1/B2 development, and the initial extrafollicular
response. Plexin-D1 expression was increased following B cell activation, and PlxnD1−/− mice
exhibited defective GC reactions during T-dependent immune activation. PlxnD1−/− B cells
showed a defect in migration toward the GC chemokines, CXCL12, CXCL13, and CCL19.
Accordingly, PlxnD1−/− mice exhibited defective production of IgG1 and IgG2b, but not IgG3
serum Ab, accompanied by reductions in long-lived bone marrow plasmacytes and recall humoral
memory responses. These data show a new role for immune plexins in the GC reaction and
generation of immunologic memory.
Plexins were initially identified as molecules involved in axon guidance during neuronal
development (1, 2). Emerging research on plexins has revealed that many of these family
members are indispensable in developmental programs of the immune system (3) and are
required for proper immune activation (4-8). Plexin-D1 was first shown to be important for
its role in vasculature formation as well as heart development (9, 10), but recent work
demonstrates its role in controlling migration of double-positive thymocytes (11). Plexins
have different ligands by which they exert their function. The primary ligands for the plexin
family of molecules are the semaphorins (3). Plexin-D1 has two known ligands,
semaphorin-4A and semaphorin-3E (11, 12). However, semaphorin-3E is the only plexin-D1
ligand that has been identified in immune tissues (11).
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Successful activation of B cells during a T-dependent (Td) immune response is essential in
providing long-term immunity (13, 14). The Td response results in follicular (FO) B cell
activation and subsequent plasma cell development and germinal center (GC) formation
(15). The initial Td response results in low-affinity Ag-specific IgM or IgG production by
short-lived plasma cells that reside in the spleen (16-18). The GC reaction, which develops
more slowly, gives rise to memory B cells and long-lived bone marrow (BM) plasma cells
that provide the rapid and robust serum Ab responses characteristic of secondary, memory
responses (16, 19). GCs are the primary sites for affinity maturation, which is characterized
by clonal expansion and somatic hypermutation (19).
Whereas many studies have addressed the GC response and the types of mechanisms
involved in its initiation and maintenance, we lack a complete understanding of this process.
Earlier work suggested that the GC is divided into two distinct compartments, the light and
dark zone (20). The dark zone is characterized by rapidly proliferating B cells (centroblasts),
which additionally undergo somatic hypermutation. The light zone is populated by FO
dendritic cells that present Ag to activated B cells and facilitate clonal selection (21). This
view has recently been revised as new data suggest that clonal selection can also occur in the
dark zone (22). GC B cells found in the dark and light zones are not as morphologically
different as originally thought (22, 23). Additionally, these studies report intrazonal
circulation of GC B cells and substantial traffic along the GC periphery where B cells are
thought to travel and receive T cell help (22, 23).
Previous studies have suggested that activated B cells specific for a foreign Ag seed the GC
within a few days after the initiation of the immune response (13, 18, 24). B cells are then
selected and continue on as long-lived plasma cells or memory B cells (22, 25, 26).
Chemokines are key regulators of the GC reaction, as follows: the chemokine receptors such
as CXCR4 and CXCR5 control formation and maintenance of GC (27-29); CXCL13 and its
receptor CXCR5 direct activated B cells to the GC light zone and are required for proper
positioning of the GC light zone (25); and CXCL12 is thought to be required for the
recruitment of CXCR4-expressing GC B cells from the light zone into the dark zone (25).
Although the identification of key chemokines and their receptors has furthered our
understanding of the GC reaction, we still lack a complete picture of the molecular
mechanisms involved in guiding B cells into and out of the GC reaction. Indeed, gene
deletion studies focusing on CXCR4- and CXCR5-dependent mechanisms have suggested
that GC formation is influenced by other, yet-to-be identified guidance molecules that traffic
activated B cells in and out of the GC (22, 25, 26, 29).
A gene-profiling report found plexinB2 as one of the genes that are expressed by GC B
cells, although the physiological relevance of this finding was not explored (30). Plexins and
their receptors, semaphorins, play significant roles in cell migration and positioning in other
immune organs and are, therefore, likely candidates to play important roles in formation and
maintenance of the GC (3). Thus, it is important to explore the physiological and functional
role of plexins in the GC reaction.
This work reveals that plexin-D1 is expressed by B lymphocytes and that expression is
greatly enhanced in activated B cells. Moreover, PlxnD1−/− B cells fail to participate
efficiently in the GC reaction. Additionally, recall immune responses are attenuated in the
absence of plexin-D1 leading to defective Ab production. These results indicate a novel
physiologic role of plexin-D1 in B cell activation.
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C57BL/6 and congenic C57BL/6 CD45.1 mice were obtained from the National Cancer
Institute (Boston, MA). PlxnD1+/− mice were a generous gift from Dr. Thomas Jessell’s
laboratory and have been described previously (9). Mice were housed in a pathogen-free
barrier facility at University of North Carolina. These studies were approved by the
University of North Carolina Animal Care and Use Committee.
For fetal liver chimeras, PlxnD1+/− mice were crossed for >10 generations with C57BL/6
mice and intercrossed to obtain PlxnD1−/− and PlxnD1+/+ embryos. PlxnD1+/+ and
PlxnD1−/− fetal livers were prepared from E14 embryos post-PCR genotyping, as previously
described (9). Five million fetal liver cells were then injected (i.v.) into lethally irradiated
C57BL/6 CD45.1 mice. Mice were analyzed 6–10 wk postreconstitution. For mixed chimera
experiments, fetal liver cells were obtained from PlxnD1−/− embryos (CD45.2) and
PlxnD1+/+ embryos (CD45.1), mixed (1:1 ratio), and injected into lethally irradiated C57BL/
6 CD45.1 recipient mice. Mice were allowed to reconstitute for 6–8 wk before use.
Immunizations
4-Hydroxy-3-nitrophenylacetyl–chicken γ-globulin immunization—Fetal liver
chimeric mice were immunized (i.p.) with 4-hydroxy-3-nitrophenylacetyl18–chicken γ-
globulin (NP18-CGG; 10 μg) precipitated in alum and suspended in 200 μl PBS. Mice were
bled before, 4 d, 7 d, 14 d, and 28 d after immunization to determine Ag-specific serum Ab
levels. Spleens were harvested 4 d, 7 d, 14 d, and 21 d postimmunization and analyzed via
FACS and immunofluorescent labeling of tissue sections. Remaining animals were boosted
with NP18-CGG (10 μg) at 28 d postprimary immunization. Serum was then collected 14 d
postboost.
NP-Ficoll immunization—Fetal liver chimeric animals were immunized (i.p.) with NP-
Ficoll (25 μg) suspended in 200 μl PBS. Mice were bled before, 3 d, and 5 d after
immunization to determine Ag-specific serum Ab levels.
ELISA
ELISA plates (BD Falcon) were coated with 2 μg/ml (50 μl/well) capture reagent goat anti-
mouse Ig(H+L), 4-hydroxy-3-nitroiodophenylacetyl (NIP)2-BSA, or NIP25-BSA in 0.1 M
carbonate buffer (pH 9.5) overnight at 4°C. Detection Abs included HRP-conjugated goat
anti-mouse IgM and goat anti-mouse IgG1, IgG2b, and IgG3 from Southern Biotechnology
Associates (Birmingham, AL). Each serum sample was diluted 1:333 and was followed by
5–10 serial 3-fold dilutions and assayed in duplicate. Purified mouse IgM and IgG mAb
were used to generate standard curves beginning at 1 μg/ml and diluted to 6 ng/ml.
In vitro B cell migration
FO (B220+CD21lowCD23high) B cells were sorted from the spleens of wild-type (WT) and
PlxnD1−/− animals and activated in the presence of anti-μ and anti-CD40 overnight. Cells
were then counted and suspended in RPMI 1640 with 0.1% fatty acid-free BSA. Cells were
resuspended at a density of 107 cells/ml and incubated at 37°C for 30 min prior to Transwell
migration assay. Media (100 μl) were added to the upper chamber of 24-well migration
plates with a pore size of 5 μm (Corning Costar). Top chambers were inserted into wells
containing 600 μl media with CCL19 (500 ng/ml), CXCL13 (500 ng/ml), or CXCL12 (150
ng/ml). Plates were incubated for 2 h at 37°C. All cells were counted by flow cytometry, as
previously described (25).
Holl et al. Page 3














Ag-specific Ab-forming cells—ELISPOT plates (Millipore) were coated with 2 μg/ml
(50 μl/well) NIP25-BSA or goat anti-mouse Ig(H+L) in 0.1 M carbonate buffer (pH 9.5)
overnight at 4°C. One million splenocytes (5 and 14 d postprimary immunization) and 1
million BM cells (14 d postboost) obtained from immunized animals were serially diluted
and plated in triplicate. Cells were incubated at 37°C in a humidified CO2 incubator for 4 h.
Plates were washed and reblocked for 24 h using blocking buffer (1× PBS [pH 7.4], 0.1%
Tween 20, and 0.5% BSA). Membranes were probed with alkaline phosphatase–conjugated
IgG (Southern Biotechnology Associates), and spots were developed with Sigma FAST 5-
bromo-4-chloro-3-indolyl phosphate/NBT (Sigma-Aldrich).
Cell culture
Proliferation assays—B cells were sorted by FACS or using a B cell-negative selection
kit (StemCell Technologies). A total of 2 × 105 purified B cells was cultured in RPMI 1640
media (Life Technologies) containing 10% FBS, 10-4 M 2-ME, and penicillin/streptomycin
antibiotics in 96-well plates. Cells were cultured in the presence of 5 μg/ml LPS (Sigma-
Aldrich) or 5 μg/ml anti-μ (Jackson ImmunoResearch Laboratories) for 48 h. A total of 1
μCi [3H]thymidine was added to the cultures for the last 8 h to assess proliferation. FACS-
sorted FO (B220+CD21lowCD23high) B cells were labeled with 5 μM CFSE (Sigma-
Aldrich) and cultured in the presence of 5 μg/ml IgM or 5 μg/ml LPS. Proliferation was
assessed by flow cytometry after 72 h.
B cell activation—FO and marginal zone (MZ) B cells were sorted from the spleens of
C57BL/6 animals and cultured in the presence of 5 μg/ml LPS (Sigma-Aldrich), 1 μg/ml
anti-μ (Jackson ImmunoResearch Laboratories), or 1 μg/ml anti-CD40 (eBiosciences, San
Diego, CA) for 72 h. RNA and cDNA for RT-PCR and quantitative real-time PCR were
prepared, as described above.
Abs and FACS
mAbs included the following: B220 (RA3-6B2), CD23 (B3B4), BP1 (6C3), CD24 (M1/69),
CD43 (S7), GL-7, and allophycocyanin Alexa750-conjugated streptavidin from BD
Pharmingen (San Diego, CA); IgM (eB121-15F9), IgD (11-26), CD21 (eBio8D9), CD93
(AA4.1), CD5 (Ly-1), CD45.2 (104), CD4 (L3T4), CD8 (Ly-2), and TCRβ (H57-597) from
eBiosciences; Igκ and Igλ from Southern Biotechnology Associates; and CD38 (90) and
IgG1 (RMG1-1) from Biolegend (San Diego, CA). Secondary Abs included anti-FITC
Alexa488, Alexa350-conjugated streptavidin, and Alexa405-conjugated streptavidin from
Invitrogen (Raleigh, NC). Single-cell suspensions of different tissues were counted, and 106
cells were suspended in FACS buffer (1× PBS plus 2% FBS) and stained with various Ab
combinations. All flow cytometry was performed on a FACSCalibur or LSRII cytometer
(BD Biosciences) and analyzed with FlowJo software (Tree Star). Cell sorting was
performed on a MoFlo cytometer (Beckman-Coulter).
Histology
Spleens from naive and immunized mice were embedded in OCT compound, snap frozen,
and stored at −80°C. Sections (5 μm) were prepared and fixed with 1:1 acetone:methanol for
10 min at −20°C and labeled with various combinations of fluorescently labeled Abs.
Additionally, sections from various spleens were H&E stained. Images were acquired using
a Zeiss Axiovert 200M or Zeiss LSM 710 confocal immunofluorescent microscope.
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Statistical significance was determined with two-tailed Student t test. All p values <0.05
were considered significant.
Results
PlxnD1 is predominantly expressed in B cells and upregulated by B cell activation
Expression of plexin-D1 in the immune system has not been fully characterized. PlxnD1
was recently shown to be expressed by double-positive thymocytes and controlled
movement within the thymus (11), indicating a role for PlxnD1 in lymphocyte development
and migration. We extended plexin-D1 expression studies from immature thymocytes to
peripheral T and B cells using RT-PCR (Fig. 1A) and quantitative real-time PCR (Fig. 1B).
PlxnD1 mRNA expression is minimally detected in peripheral CD4 and CD8 T cells and in
mature T cells that have been cultured under Th1 and Th2 skewing conditions. To
characterize plexin-D1 expression in B cells, splenic (FO)
(B220+IgDhighIgMlowCD21lowCD23high) and MZ (B220+IgDlowIgMhighCD21highCD23low)
B cells were isolated by flow cytometry. As shown by both RT-PCR and real-time PCR,
PlxnD1 mRNA was minimally expressed by resting naive FO B cells, slightly elevated in
the GC B cell compartment, but highly expressed by MZ B cells (Fig. 1). Activation of
sorted FO B cells with LPS, anti-IgM, and anti-CD40 resulted in dramatically increased (20-
to 30-fold) plexin-D1 expression, suggesting that this gene might play a role in B cell
immune responses (Fig. 1B). Thus, in peripheral lymphoid organs, plexin-D1 is
constitutively expressed by MZ B cells and is upregulated in FO B cells upon activation.
These data suggest that plexin-D1 expression is associated with activated B cell populations.
PlxnD1−/− B cells exhibit normal development and in vitro activation profiles in mice
engrafted with PlxnD1−/− fetal liver cells
Conventional plxnD1 gene inactivation in mice results in embryonic lethality, thereby
prohibiting any study of a fully developed immune system (10). To determine whether the
absence of plexin-D1 affects lymphocyte development, lethally irradiated C57BL/6 CD45.1
mice were reconstituted with either WT or PlxnD1−/− fetal liver cells. Donor and recipient
hematopoietic cell populations were readily distinguished based on the expression of the
CD45.1 (host) or CD45.2 (donor) allelic markers. Hematopoietic reconstitution of irradiated
mice receiving either WT or PlxnD1−/− fetal liver was >90%, as assessed by flow cytometric
analysis of splenocytes (Fig. 2Ai).
We analyzed B cell development in the BM of PlxnD1−/− and WT control mice by the
criteria of Hardy, based on expression of B220, CD43, BP1, and heat stable Ag (HSA) (Fig.
2Aii, 2Aiii) (31). B220+CD43high cells were separated into three populations, as follows:
BP1−HSA−, BP1−HSA, and BP1+HSA+: A (prepro-B cells), B (pro-B cells), and C (late
pro-B cells). BM of PlxnD1−/− and WT control animals showed no difference in the
percentage of pro-B cells and pre-B cells (Fig. 2Aiii). These data demonstrate that
expression of plexin-D1 is not required to generate early progenitor B cell compartments.
To evaluate B cell development and maturation, we examined the splenic B cell
compartments of PlxnD1−/− and WT control animals using mAbs to B220, IgM, IgD, CD21,
CD23, and CD93. The immature transitional B cell compartments, defined by IgM, CD23,
and CD93 expression (32), were similar in PlxnD1−/− and WT animals, suggesting that B
cell development in the spleen is normal (Supplemental Fig. 1A). FO B cell (IgMintIgDhigh)
frequencies were also comparable between PlxnD1−/− and WT control animals (Fig. 2Aiv).
In contrast, when MZ B cells were examined, there was a 2-fold reduction in the percentage
of these cells in PlxnD1−/− mice compared with WT controls, whereas FO B cell
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percentages remained unchanged, thus suggesting a potential importance of plexin-D1 in
MZ function (Fig. 2B). All data, including total cell numbers, are compiled in Supplemental
Table 1. In addition, we examined the B cell compartment in the peritoneal cavity of
PlxnD1−/− animals and no differences were found in the percentages and numbers of B1 and
B2 compartments (Supplemental Fig. 1B).
The proliferation of PlxnD1−/− B cells in response to anti-IgM or LPS stimulation as
determined by [3H]thymidine incorporation (Fig. 2C) or CFSE dilution (Fig. 2D) was
normal in PlxnD1−/− FO and MZ B cells. Histological studies of the spleen revealed normal
splenic architecture in PlxnD1−/− mice, as determined by characteristic white and red pulp
structure (Fig. 2E). These data suggest that plexin-D1 is dispensable for B cell proper
localization in the spleen.
PlxnD1−/− animals have attenuated GC responses
The reduction in the percentage of MZ B cells in PlxnD1−/− animals compared with WT led
us to investigate whether humoral immune responses were affected by the absence of plexin-
D1. We analyzed basal Ig levels in WT and PlxnD1−/− sera by ELISA. Basal total IgM and
IgG3 were comparable between WT and PlxnD1−/− animals, but IgG1 and IgG2b levels
were significantly reduced in PlxnD1−/− mice compared with WT mice (Fig. 2F).
The defect in Td Ig class switching could be attributed to impaired GC reactions in
PlxnD1−/− animals. GCs are pivotal sites for facilitating Ig class switching, and we analyzed,
therefore, the formation of GCs in the spleens of PlxnD1−/− and control mice after NP-CGG
immunization (15). Spleens were harvested on day 14 postimmunization, and splenocytes
were analyzed by flow cytometry to determine the frequency of B220highGL-7high GC B
cells (29) present within the total B220+ population. Whereas there was no difference at
naive state, PlxnD1−/− animals showed a lower percentage of GC B cells when compared
with WT postimmunization (Fig. 3A). We observed a 2-fold reduction in the percentage and
numbers of GC B cells for PlxnD1−/− mice, at days 7, 14, and 21, compared with WT (p <
0.01) (Fig. 3B, Supplemental Table 1). There was no significant difference in the
percentages of B220highGL-7+ B cells between WT and PlxnD1−/− mice at day 4, suggesting
that the kinetics of GC onset were not changed by plexin-D1 (Fig. 3B). Splenic cryosections
were labeled with mAbs to TCRβ, B220, and GL-7 to determine whether GCs form in
PlxnD1−/− mice. PlxnD1−/− animals showed a reduction in the size of the GCs as determined
by histology at day 14 (Fig. 3C). B cell contribution to GC formation was entirely of donor
origin (Supplemental Fig. 2A). Additionally, we stained splenic sections with CD21 to
determine the dark and light zone of the GCs in WT and PlxnD1−/− animals (Supplemental
Fig. 2B). Our data demonstrate that dark and light zones are present in both WT and
PlxnD1−/− mice despite the size of the GCs.
To expand the analysis of GC frequency in WT and PlxnD1−/− mice, five to eight nonserial
sections were prepared from immunized spleen samples. The number of GCs was counted
and normalized to the number of follicles per section to account for differences in area.
These results showed that the number of follicles that contained GCs was lower in the
PlxnD1−/− animals compared with WT controls (Fig. 4A). To quantify the difference in GC
size between PlxnD1−/− and WT animals, the area of individual GCs was measured using
ImageJ software. Whereas WT animals showed a higher distribution of the medium and
large GCs, PlxnD1−/− mice contained an elevated frequency of small GCs and a reduced
frequency of large GCs (Fig. 4B). A compilation of >200 GC/mouse type shows that the size
of GCs in PlxnD1−/− mice is reduced by ~2-fold compared with the WT controls (Fig. 4C).
Taken together, these data demonstrate that hematopoietic-derived plexin-D1 controls both
the number and size of GCs formed during immunization.
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The NP-hapten elicits a restricted Ab response to Ighb/λ1 mice (33). To exclude the
possibility that the differences we observed in the GC reaction are a result of different
frequencies of Igλ+ B cells in the absence of plexin-D1, we enumerated Igλ+ B cells in
PlxnD1−/− mice and found comparable percentages and distributions of Igλ+ B cells to WT
(Supplemental Fig. 3A, 3B). We also determined the presence of Igλ+ cells in the GCs of
WT and PlxnD1−/− mice (Supplemental Fig. 3C).
PlxnD1−/− B cells participate in the GC reaction less efficiently than WT B cells
To determine whether the expression of plexin-D1 was required for optimal GC formation,
irradiated WT mice were reconstituted with fetal liver cells from PlxnD1−/− and WT mice
(Fig. 5A). After 8 wk, double chimera mice were immunized with NP-CGG. Fourteen days
after immunization, spleens from immunized and naive mice were analyzed by flow
cytometry and histology. The reconstitution of irradiated recipients by WT and PlxnD1−/− B
cells was similar (Fig. 5B). We determined the frequency of GC B cells (B220highGL-7high)
in the chimeric mice postimmunization. Flow cytometry analysis revealed a near 3-fold
decrease in the percentage of GC B cells derived from PlxnD1−/− fetal liver cells compared
with WT (Fig. 5B, 5C). Results obtained from six individual mice are compiled in Fig. 5C.
Additionally, we performed immunofluorescence staining on sections obtained from the
spleens of chimeric mice to determine the presence of WT or PlxnD1−/− B cells in the GC
(Fig. 5Di). We observed a lack of CD45.2+ PlxnD1−/− B cells in >70% of the GC examined.
In a competitive environment, PlxnD1−/− B cells are less efficient than WT cells in entering
GC. Additionally, we stained splenic sections with CD21 to define the light zone of the GC.
We observed abundant CD45.1+ WT, but only occasional CD45.2+ PlxnD1−/− B cells in the
light zone of the GCs (Fig. 5Dii). The majority of PlxnD1−/− B cells accumulated around the
GCs. These data are consistent with the results obtained earlier with PlxnD1−/− mice to
indicate that formation of GC is impaired.
PlxnD1−/− B cells exhibit reduced migration to CXCL12, CXCL13, or CCL19
To investigate possible mechanisms behind the reduced size and frequency of GC in
PlxnD1−/− mice, the response to B cell chemokines involved in GC recruitment (CXCL12,
CXCL13, and CCL19) was measured using an in vitro Transwell migration assay performed
with naive and activated B cells.
In addition to the in vivo experiment described in Fig. 5 in which WT and PlxnD1−/− B cells
were assessed for their participation in the GC in a competitive assay, we performed an
analogous experiment in which naive or activated WT and PlxnD1−/− B cells were
combined in an in vitro competitive B cell migration assay toward CXCL12, CXCL13, and
CCL19. Migration of B cells was quantified by flow cytometry, and data are presented as
the percentage of migrating B cells over input. Migration of naive B cells toward these
chemokines was not affected (Supplemental Fig. 4A). However, migration of activated B
cells was uniformly reduced in PlxnD1−/− cells compared with WT B cells in the same wells
(Fig. 6A). We also assessed the cell surface expression of receptors for CCL19, CXCL12,
and CXCL13 by flow cytometry. We did not observe significant differences in cell surface
expression for CCR7, CXCR4, and CXCR5 in naive or activated B cells (data not shown),
indicating that the lack of responsiveness to chemokines was not due to lowered expression
of the associated chemokine receptors. These observations demonstrate that plexin-D1
regulates B cell migratory responses to a panel of chemokines important for GC reaction.
Additionally, we assessed T cell migration in vitro in response to CXCL12 and CCL19
chemokines. T cell migration was not affected in the absence of plexin-D1 as compared with
WT mice (Supplemental Fig. 4B).
Holl et al. Page 7













To determine whether the loss of GC B cells in the absence of plexin-D1 was associated
with altered GC B cell proliferation, we quantified the percentages of proliferating GC B
cells by BrdU incorporation at day 14 postimmunization. As shown in Fig. 6B, absence of
plexin-D1 does not affect the proliferation rate of GC B cells. Similarly, BrdU incorporation
in non-GC B cells is comparable between PlxnD1−/− and WT animals (Supplemental Fig.
5). Additionally, we determined whether diminished GC B cells were due to increased B cell
death in the absence of plexin-D1. To this end, we employed TUNEL staining. As shown in
Fig. 6C, the numbers of TUNEL+ cells were comparable between WT and PlxnD1−/− GCs.
Together, these data suggest that decreased numbers of GC B cells in the absence of plexin-
D1 are not due to diminished in vivo B cell proliferation or increased B cell death. We
attribute the decreased ability of PlxnD1−/− animals to form robust GCs to the inability of B
cells to efficiently migrate into the GCs in the absence of plexin-D1.
PlxnD1−/− mice show attenuated secondary humoral immune response
Given the impaired GC response of PlxnD1−/− chimeras, we examined the generation of
humoral immune memory in these mice. The GC reaction is crucial for the efficient
production of memory B cells and long-lived BM plasma cells, which comprise the cellular
memory compartments (16, 19). To measure memory B cell responses, WT and PlxnD1−/−
mice were immunized with NP-CGG in alum and then boosted with NP-CGG 28 d
postprimary immunization. Serum samples were collected before immunization, 7 d, 14 d,
and 28 d postprimary immunization, and 14 d after secondary boost. An ELISA to determine
both total- and high-affinity serum Ab was performed with all serum samples.
Naive PlxnD1−/− or WT mice contained low to undetectable levels of NP-reactive IgG1 Ab,
whereas 14 d postimmunization NP-specific Ab levels in these mice increased (~1000-fold)
(Fig. 7A). Primary serum Ab responses of PlxnD1−/− and WT animals did not differ (p >
0.05) in high- or total-affinity Ab levels (Fig. 7A, 7B). Secondary Ab responses, however,
were significantly reduced (p < 0.05) in PlxnD1−/− mice compared with WT for both low-
and high-affinity Ab (Fig. 7A, 7B). These results showed that the initial immune response in
PlxnD1−/− mice is similar to WT controls, whereas a secondary challenge revealed that the
recall response is suboptimal in PlxnD1−/− mice. To determine the effect of plexin-D1 in
affinity maturation, we obtained the ratio of NP2/NP25 (Fig. 7C).
To examine whether Ag-specific class switching Ab-forming cells (AFC) were affected in
PlxnD1−/− animals, we performed ELISPOT assays to determine the frequencies of NP-
specific IgG-secreting cells in the spleens of immunized mice at 5 and 14 d after primary
immunization. The number of splenic NP-specific AFC increased after immunization
compared with naive controls in both WT and PlxnD1−/− animals. However, the frequency
of NP-specific IgG AFC was lower in PlxnD1−/− animals compared with WT animals at day
14, but not at day 5 after primary immunization (Fig. 7D). Interestingly, we did not observe
a difference in the numbers of NP-specific IgM AFC at day 5 and 14 postimmunization,
suggesting that formation of nonclass-switched plasma cells is normal in PlxnD1−/− animals
(Supplemental Fig. 6). Taken together, these data suggest that initial extrafollicular
responses in PlxnD1−/− mice are intact. We also compared the levels of NP-specific AFC in
the BM of PlxnD1−/− or WT control animals following a secondary boost where long-lived,
memory AFC reside. PlxnD1−/− mice exhibited a reduction of NP-specific IgG AFC
following secondary challenge (Fig. 7E). We correlate a reduction in the frequency of NP-
specific AFC with reduced levels of IgG1 observed at day 42, which is 14 d after the
secondary challenge.
Taken together, these data suggest that although initial AFC formation is normal in
PlxnD1−/− mice, the continued generation of these cells is reduced as compared with WT
controls.
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We also examined the role of plexin-D1 during a T-independent immune response by
immunizing PlxnD1−/− and WT mice with NP-Ficoll in PBS. There were no significant
differences in the levels of NP-specific serum IgM between WT and PlxnD1−/− mice in
response to NP-Ficoll (Supplemental Fig. 7). Thus, plexin-D1 expression on B cells appears
to specifically regulate GCs and the formation of humoral immune memory associated with
Td responses.
Discussion
This study identifies a novel role for plexin-D1 in B cell biology and, to our knowledge,
represents the first demonstration of a plexin molecule that affects GC formation and
humoral immune memory. In our study, PlxnD1 was expressed at low levels by FO B cells
and substantially induced by LPS, IgM, or CD40 engagement. Despite its relative abundance
in activated B cells, plexin-D1 was not required for FO B cell development and maturation
as all B cell subpopulations tested were present in normal frequencies in the BM, spleen,
peritoneal cavity, and lymph nodes of PlxnD1−/− animals.
The enhancement of PlxnD1 expression by B cells following activation suggested a role for
this molecule during the course of an immune response. Indeed, immunization with Td Ags
resulted in a reduced memory IgG1 response in PlxnD1−/− mice compared with the WT
mice, accompanied by reduced size and numbers of splenic GCs. The GC is a primary site
for class switch recombination, affinity maturation, and plasma cell and memory cell
development (13, 18, 29). The reduced frequency of GC B cells was followed by a
significant reduction in Ag-specific AFC formation in the BM following secondary
challenge. The size and frequency of GCs are important in providing a pool of B cells that
develop into AFC-producing class-switched Ab (29). Plexin-D1 is important in controlling
these events and, thereby, ensures robust humoral responses. Additionally, Plexin-D1 may
be important in specifically regulating either the generation or maintenance of memory B
cells. Both of these events are needed to provide a robust memory immune response, and
defects in either compartment can result in ablated Ab responses (17, 21).
Defects in the GC reaction can be the result of abnormal structural organization of lymphoid
tissues (34). For example, LTα−/− mice have disturbed splenic architecture due to the
inability of T and B cells to form distinct T and B cell zones (35). This phenomenon leads to
unsuccessful IgG responses in these mice following immunization (35).
Immunohistochemistry analysis of PlxnD1−/− spleens revealed normal splenic architecture,
suggesting that the separation of B and T cells into distinct compartments is unaffected in
these animals. Moreover, these data suggest that homing of B and T cells into secondary
lymphoid organs is intact in the absence of plexin-D1.
Early T-independent immune responses in PlxnD1−/− animals are not affected, in the context
of the NP-Ficoll response, despite a reduction in the number of MZ B cells. This suggests
differential requirements for plexin-D1 during the course of an in vivo immune response
controlled by different B cell subtypes. These data resemble the phenotype observed in
Rap1b−/− animals in which the MZ B cell compartment is reduced due to the role of rap1b in
controlling integrin functions (36). However, Rap1b−/− mice exhibit unaltered FO B cell
compartments. MZ B cells can participate in the Td immune response by acting as APCs and
shuttling in and out of the follicles (37). A reduction in MZ B cell numbers can result in
altered Td responses. However, assessment of early Td responses in PlxnD1−/− mice
suggests that the phenotype observed in the absence of plexin-D1 is probably not due to the
reduced numbers of MZ B cells.
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Plexins were originally identified in the nervous system as receptors for semaphorins, a
large class of both secreted and membrane-bound glycoproteins (38). Plexins are grouped
into four different families (A, B, C, and D) based on their structural homology (38).
Semaphorins are divided into eight subclasses, as follows: classes 1 and 2 belong to
invertebrates, classes 3–7 belong to vertebrates, and class 8 belongs to viruses. Semaphorins
can bind to their primary receptors, plexins, alone, or in the presence of neuropilin receptors.
Plexins control cell adhesion via their intracellular domains, which contain GTPase-binding
structures and are responsible for an array of signaling cascades (39, 40). Absence of plexins
can lead to impaired immune responses controlled by various cell types (4-8).
The importance of plexin-D1 in cell adhesion and migration has been demonstrated in both
the vascular and immune system. Absence of plexin-D1 results in aberrant vasculature
patterning and growth via mechanisms that involve R-Ras and Arf6 (9, 40). In the immune
system, absence of plexin-D1 results in impaired activated thymocyte migration toward
CXCL12 and CCL23 chemokines (11). We extend these studies to show a role for plexin-
D1 in B cell movement in peripheral lymphoid organs. In vivo, lack of plexin-D1 results in
impaired B cell movement and participation in the GC. In vitro, migration of plexin-D1–
deficient B cells toward chemokines that are implicated in Td immune responses as well as
the GC reaction is impaired. CCL19 has been implicated in recruiting B cells to the spleen
and further contributing to their ability to travel and scan different areas in search for their
cognate Ag (41, 42). Additionally, CXCL13 is highly expressed in the spleen and is required
for migration of B cells to the follicles and subsequently to nascent GCs (25, 28). CCL19,
CXCL12, and CXCL13 are thought to be important in setting up GCs and additionally
regulating recruitment of B cells to the light and dark zones (25). Our in vitro migration
experiments revealed that activated B cells had a reduction in migration abilities toward the
tested chemokines, CXCL12, CXCL13, and CCL19. This occurred despite the fact that the
receptors for these chemokines were expressed at normal levels by PlxnD1−/− B cells. These
findings suggest that plexin-D1 may be important in allowing activated B cells to enter the
GC in vivo by facilitating effective migration toward GC chemokines. Upregulation of
plexin-D1 expression by activated B cells may be an important mechanism that initiates
activated B cell movement and prompts Ag-specific B cells to participate in the GC reaction.
Once this process is initiated, GC B cells downregulate plexin-D1 perhaps as a mechanism
to facilitate their retention in the GC. We have identified a novel mechanism regulating B
cell migration to GC chemokines that is distinct from chemokine receptor expression. The
stage at which the defect in the GC response occurs needs to be established. It is possible
that this defect occurs prior to the initiation of the GC reaction and absence of plexin-D1 in
activated B cells blocks participation of activated B cells in the GC response. Moreover, the
mechanisms underlying the ability of plexin-D1 to specifically regulate migration of GC B
cells to CXCL12, CXCL13, and CCL19 will be examined in future studies.
The importance of plexins and semaphorins in controlling immune cell development and
immune responses is recently being appreciated. For example, Plexin-B1 is required for
proliferation and survival of B cells (4). Plexin-A1 expression by DCs is needed for proper
T cell activation and proliferation via control of rho activation and actin polarization events
in DCs (8, 43). Plexin-A4 is a negative regulator of T cell immune responses, and its
absence leads to development of autoimmunity in mice lacking plexin-A4 (5). Most
recently, expression of plexin-B2 in B cells was used to identify GCs (30). In this study, we
have identified plexin-D1 as a novel regulator of humoral immune memory. Some of the
defects observed over the course of Td immune responses could be attributed to the inability
of activated PlxnD1−/− B cells to migrate to the GC. These studies show that a single
member of the plexin family can exert various functions on different cell types (T and B)
depending on the stage of cell development or the state of immune activation. Further
studies involving PlxnD1−/− T cells and B cells are needed to define the role of this
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molecule in different types of immune responses. Plexin-D1 is, to our knowledge, the first
plexin shown to be directly involved in the control of GCs and consequently control of
humoral immune memory. This finding has implications in vaccine design in terms of
targeting the GC and promoting long-term immunity.
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Acknowledgments
We thank Dr. Robert Bagnell at the Microscopy Services Laboratory for assistance with microscopy.
This work was supported by University of North Carolina Developmental Biology Training Program Grant
HD046369 (to E.K.H.), National Institutes of Health Grant AI29564 (to J.P.-Y.T.), National Institutes of Health
Grant AI024335 (to G.K.), National Institutes of Health T32 Training Grant AI007151 (to A.G.Z.), National
Institutes of Health T32 Lineberger Postdoctoral Training Grant (to B.P.O.), National Institutes of Health F32
Postdoctoral Grant (to B.P.O.), and an Irvington Institute Postdoctoral Fellowship from the Cancer Research
Institute (to B.P.O.).
References
1. Winberg ML, Noordermeer JN, Tamagnone L, Comoglio PM, Spriggs MK, Tessier-Lavigne M,
Goodman CS. Plexin A is a neuronal semaphorin receptor that controls axon guidance. Cell. 1998;
95:903–916. [PubMed: 9875845]
2. Kolodkin AL, Matthes DJ, Goodman CS. The semaphorin genes encode a family of transmembrane
and secreted growth cone guidance molecules. Cell. 1993; 75:1389–1399. [PubMed: 8269517]
3. Suzuki K, Kumanogoh A, Kikutani H. Semaphorins and their receptors in immune cell interactions.
Nat Immunol. 2008; 9:17–23. [PubMed: 18087252]
4. Granziero L, Circosta P, Scielzo C, Frisaldi E, Stella S, Geuna M, Giordano S, Ghia P, Caligaris-
Cappio F. CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic
CD5+ B lymphocytes. Blood. 2003; 101:1962–1969. [PubMed: 12406905]
5. Yamamoto M, Suzuki K, Okuno T, Ogata T, Takegahara N, Takamatsu H, Mizui M, Taniguchi M,
Chédotal A, Suto F, et al. Plexin-A4 negatively regulates T lymphocyte responses. Int Immunol.
2008; 20:413–420. [PubMed: 18209113]
6. Walzer T, Galibert L, De Smedt T. Dendritic cell function in mice lacking Plexin C1. Int Immunol.
2005; 17:943–950. [PubMed: 15967782]
7. O’Connor BP, Eun SY, Ye Z, Zozulya AL, Lich JD, Moore CB, Iocca HA, Roney KE, Holl EK,
Wu QP, et al. Semaphorin 6D regulates the late phase of CD4+ T cell primary immune responses.
Proc Natl Acad Sci USA. 2008; 105:13015–13020. [PubMed: 18728195]
8. Wong AW, Brickey WJ, Taxman DJ, van Deventer HW, Reed W, Gao JX, Zheng P, Liu Y, Li P,
Blum JS, et al. CIITA-regulated plexin-A1 affects T-cell-dendritic cell interactions. Nat Immunol.
2003; 4:891–898. [PubMed: 12910265]
9. Gu C, Yoshida Y, Livet J, Reimert DV, Mann F, Merte J, Henderson CE, Jessell TM, Kolodkin AL,
Ginty DD. Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins.
Science. 2005; 307:265–268. [PubMed: 15550623]
10. Gitler AD, Lu MM, Epstein JA. PlexinD1 and semaphorin signaling are required in endothelial
cells for cardiovascular development. Dev Cell. 2004; 7:107–116. [PubMed: 15239958]
11. Choi YI, Duke-Cohan JS, Ahmed WB, Handley MA, Mann F, Epstein JA, Clayton LK, Reinherz
EL. PlexinD1 glycoprotein controls migration of positively selected thymocytes into the medulla.
Immunity. 2008; 29:888–898. [PubMed: 19027330]
12. Chauvet S, Cohen S, Yoshida Y, Fekrane L, Livet J, Gayet O, Segu L, Buhot MC, Jessell TM,
Henderson CE, Mann F. Gating of Sema3E/PlexinD1 signaling by neuropilin-1 switches axonal
repulsion to attraction during brain development. Neuron. 2007; 56:807–822. [PubMed:
18054858]
Holl et al. Page 11













13. Jacob J, Kassir R, Kelsoe G. In situ studies of the primary immune response to (4-hydroxy-3-
nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations. J Exp Med.
1991; 173:1165–1175. [PubMed: 1902502]
14. Blink EJ, Light A, Kallies A, Nutt SL, Hodgkin PD, Tarlinton DM. Early appearance of germinal
center-derived memory B cells and plasma cells in blood after primary immunization. J Exp Med.
2005; 201:545–554. [PubMed: 15710653]
15. Jacob J, Kelsoe G. In situ studies of the primary immune response to (4-hydroxy-3-
nitrophenyl)acetyl. II. A common clonal origin for periarteriolar lymphoid sheath-associated foci
and germinal centers. J Exp Med. 1992; 176:679–687. [PubMed: 1512536]
16. Allen CD, Okada T, Cyster JG. Germinal-center organization and cellular dynamics. Immunity.
2007; 27:190–202. [PubMed: 17723214]
17. Jacob J, Kelsoe G, Rajewsky K, Weiss U. Intraclonal generation of antibody mutants in germinal
centres. Nature. 1991; 354:389–392. [PubMed: 1956400]
18. Liu YJ, Zhang J, Lane PJ, Chan EY, MacLennan IC. Sites of specific B cell activation in primary
and secondary responses to T cell-dependent and T cell-independent antigens. Eur J Immunol.
1991; 21:2951–2962. [PubMed: 1748148]
19. Jacob J, Przylepa J, Miller C, Kelsoe G. In situ studies of the primary immune response to (4-
hydroxy-3-nitrophenyl)acetyl. III. The kinetics of V region mutation and selection in germinal
center B cells. J Exp Med. 1993; 178:1293–1307. [PubMed: 8376935]
20. Close PM, Pringle JH, Ruprai AK, West KP, Lauder I. Zonal distribution of immunoglobulin-
synthesizing cells within the germinal centre: an in situ hybridization and immunohistochemical
study. J Pathol. 1990; 162:209–216. [PubMed: 2125071]
21. Kelsoe G. Life and death in germinal centers (redux). Immunity. 1996; 4:107–111. [PubMed:
8624801]
22. Hauser AE, Junt T, Mempel TR, Sneddon MW, Kleinstein SH, Henrickson SE, von Andrian UH,
Shlomchik MJ, Haberman AM. Definition of germinal-center B cell migration in vivo reveals
predominant intrazonal circulation patterns. Immunity. 2007; 26:655–667. [PubMed: 17509908]
23. Allen CD, Okada T, Tang HL, Cyster JG. Imaging of germinal center selection events during
affinity maturation. Science. 2007; 315:528–531. [PubMed: 17185562]
24. Wang Y, Carter RH. CD19 regulates B cell maturation, proliferation, and positive selection in the
FDC zone of murine splenic germinal centers. Immunity. 2005; 22:749–761. [PubMed: 15963789]
25. Allen CD, Ansel KM, Low C, Lesley R, Tamamura H, Fujii N, Cyster JG. Germinal center dark
and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol. 2004; 5:943–952.
[PubMed: 15300245]
26. Schwickert TA, Lindquist RL, Shakhar G, Livshits G, Skokos D, Kosco-Vilbois MH, Dustin ML,
Nussenzweig MC. In vivo imaging of germinal centres reveals a dynamic open structure. Nature.
2007; 446:83–87. [PubMed: 17268470]
27. Freedman AS, Munro JM, Rice GE, Bevilacqua MP, Morimoto C, McIntyre BW, Rhynhart K,
Pober JS, Nadler LM. Adhesion of human B cells to germinal centers in vitro involves VLA-4 and
INCAM-110. Science. 1990; 249:1030–1033. [PubMed: 1697696]
28. Förster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. A putative chemokine receptor,
BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of
the spleen. Cell. 1996; 87:1037–1047. [PubMed: 8978608]
29. Arnold CN, Campbell DJ, Lipp M, Butcher EC. The germinal center response is impaired in the
absence of T cell-expressed CXCR5. Eur J Immunology. 2007; 37:100–109. [PubMed: 17171760]
30. Yu D, Cook MC, Shin DM, Silva DG, Marshall J, Toellner KM, Havran WL, Caroni P, Cooke
MP, Morse HC, et al. Axon growth and guidance genes identify T-dependent germinal centre B
cells. Immunol Cell Biol. 2008; 86:3–14. [PubMed: 17938642]
31. Li YS, Wasserman R, Hayakawa K, Hardy RR. Identification of the earliest B lineage stage in
mouse bone marrow. Immunity. 1996; 5:527–535. [PubMed: 8986713]
32. Wilker PR, Kohyama M, Sandau MM, Albring JC, Nakagawa O, Schwarz JJ, Murphy KM.
Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor
stimulation. Nat Immunol. 2008; 9:603–612. [PubMed: 18438409]
Holl et al. Page 12













33. Rajewsky K. Clonal selection and learning in the antibody system. Nature. 1996; 381:751–758.
[PubMed: 8657279]
34. Matsumoto M, Lo SF, Carruthers CJ, Min J, Mariathasan S, Huang G, Plas DR, Martin SM, Geha
RS, Nahm MH, Chaplin DD. Affinity maturation without germinal centres in lymphotoxin-alpha-
deficient mice. Nature. 1996; 382:462–466. [PubMed: 8684487]
35. De Togni P, Goellner J, Ruddle NH, Streeter PR, Fick A, Mariathasan S, Smith SC, Carlson R,
Shornick LP, Strauss-Schoenberger J, et al. Abnormal development of peripheral lymphoid organs
in mice deficient in lymphotoxin. Science. 1994; 264:703–707. [PubMed: 8171322]
36. Chen Y, Yu M, Podd A, Wen R, Chrzanowska-Wodnicka M, White GC, Wang D. A critical role
of Rap1b in B-cell trafficking and marginal zone B-cell development. Blood. 2008; 111:4627–
4636. [PubMed: 18319399]
37. Martin F, Kearney JF. Marginal-zone B cells. Nat Rev Immunol. 2002; 2:323–335. [PubMed:
12033738]
38. Kruger RP, Aurandt J, Guan KL. Semaphorins command cells to move. Nat Rev Mol Cell Biol.
2005; 6:789–800. [PubMed: 16314868]
39. Oinuma I, Ishikawa Y, Katoh H, Negishi M. The Semaphorin 4D receptor Plexin-B1 is a GTPase
activating protein for R-Ras. Science. 2004; 305:862–865. [PubMed: 15297673]
40. Sakurai A, Gavard J, Annas-Linhares Y, Basile JR, Amornphimoltham P, Palmby TR, Yagi H,
Zhang F, Randazzo PA, Li X, Weigert R, Gutkind JS, et al. Semaphorin 3E initiates anti-
angiogenic signaling through Plexin-D1 by regulating Arf6 and R-Ras. Mol Cell Biol.
41. Okada T, Miller MJ, Parker I, Krummel MF, Neighbors M, Hartley SB, O’Garra A, Cahalan MD,
Cyster JG. Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile
conjugates with helper T cells. PLoS Biol. 2005; 3:e150. [PubMed: 15857154]
42. Okada T, Ngo VN, Ekland EH, Förster R, Lipp M, Littman DR, Cyster JG. Chemokine
requirements for B cell entry to lymph nodes and Peyer’s patches. J Exp Med. 2002; 196:65–75.
[PubMed: 12093871]
43. Eun SY, O’Connor BP, Wong AW, van Deventer HW, Taxman DJ, Reed W, Li P, Blum JS,
McKinnon KP, Ting JP. Cutting edge: rho activation and actin polarization are dependent on
plexin-A1 in dendritic cells. J Immunol. 2006; 177:4271–4275. [PubMed: 16982860]












Holl et al. Page 13














Expression of plexin-D1 by lymphocytes. A, Expression of PlxnD1 in the spleen, resting
CD4 and CD8 T cells, MZ and FO B cells, and Th1 and Th2 cells, assessed by RT-PCR.
Data are representative of three independent experiments. B, Expression of PlxnD1 in sorted
resting T cells; FO, GC, and MZ B cells; and activated B cells, as assessed by real-time
PCR. All values were normalized to HPRT. B cells were cultured in the presence of LPS (5
μg/ml), anti-μ (1 μg/ml), or anti-CD40 (1 μg/ml) for 72 h. Data are representative of three
independent experiments. Mean ± SEM. n = 8 mice.
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Normal in vitro function exhibited by PlxnD1−/− B cells. A, Reconstitution of irradiated
recipients with WT and PlxnD1−/− fetal liver cells. mAb to CD45.2 was used to label
splenocytes and to determine the percentage of reconstitution. WT and PlxnD1−/− fetal liver
cells reconstituted equally well (i). mAbs to B220 and CD43 (ii), and HSA and BP1 (iii)
were used to determine the percentages of B cell progenitors in the BM using Hardy’s
fractionation (ii, iii). mAbs to B220, IgM, and IgD were used to determine the percentage of
mature FO B cell population in the spleen (iv). Plots are pregated on live CD45.2+B220+
lymphocytes. Data are representative of 10 mice for each genotype. Mean percentage ±
SEM is indicated for each cell type. B, mAbs to CD45.2, B220, CD21, and CD23 were used
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to determine the percentage of MZ B cell populations in the spleen, WT (■), and PlxnD1−/−
(□). Plots were pregated on B220+ splenocytes. Graph represents data pooled from nine
mice in three different experiments. **p < 0.01. C, Proliferation of B cells from mice
reconstituted with PlxnD1−/− and WT fetal liver cells, as assessed by [3H]thymidine uptake.
WT (■) or PlxnD1−/− (□) FO B cells were cultured in the presence of 5 μg/ml anti-IgM or 5
μg/ml LPS for 48 h. Cells were pulsed with [3H]thymidine for the last 8 h in culture to
determine cell proliferation, and data are presented as cpm. n = 9 mice per group. Data are
representative of three independent experiments. D, Proliferation of PlxnD1−/− and WT B
cells, as assessed by CFSE dilution. Data are representative of three independent
experiments. n = 9 mice per group. E, Splenic structure of mice reconstituted with
PlxnD1−/− and WT fetal liver cells. H&E staining of 5-μm spleen cryosections was
performed. Five spleens were analyzed for each genotype. F, Serum Ig levels in mice
reconstituted with PlxnD1−/− and WT fetal liver cells. Data were pooled from three
independent experiments. n = 9–14 mice per group.
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Impaired GC response in PlxnD1−/− mice. A, Reduced frequency of GC B cells in mice
reconstituted with PlxnD1−/− cells relative to those with WT cells, as measured by flow
cytometry. Mice were immunized (i.p.) with 10 μg NP18-CGG in alum and spleens were
harvested at day 14 postimmunization. The percentage of B220highGL-7high B cells of total
B220high cells was determined by flow cytometry. B, Reduced frequency of GC B cells in
PlxnD1−/− (○) mice relative to WT (●) mice. Quantification of GC B cells as measured by
flow cytometry. The graph is representative of three independent experiments. Each point
represents data from one mouse. Small horizontal bars indicate mean values. **p < 0.001. C,
Reduction of GC size in mice reconstituted with PlxnD1−/− cells relative to those with WT
cells, as measured by histology. Sections (5 μm) of spleens from WT and PlxnD1−/− mice at
day 14 postimmunization were labeled with B220–AF350 (blue), TCRβ–PE (red), and
GL-7–FITC (green) Abs. FITC signal was amplified using anti–FITC-AF488 Ab. Images
were acquired using a Zeiss Axiovert 200M confocal immunofluorescent microscope. Day 0
samples are shown as control. n = 10 mice per group.
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Decreased number and size of GCs in PlxnD1−/− mice. A, Reduced GC number in
PlxnD1−/− (○) mice than WT (●). Number of GCs was counted using five to eight different
5-μm sections for each mouse spleen divided by the total number of B cell follicles. Each
point represents data from one mouse. Data were pooled from three independent
experiments. Small horizontal bars indicate mean values. **p < 0.001. B, Reduced
percentage of larger GC in mice reconstituted with PlxnD1−/− cells (□) compared with WT
(■). GCs were divided into three groups, as follows: small (<12,000 μm2), medium
(12,000–25,000 μm2), and large (>25,000 μm2). The number of GCs in each group was
divided by the total number of GCs and was presented as a percentage. More than 200 GCs
were analyzed for each group. C, Reduced GC area in PlxnD1−/− mice. Area of individual
GCs was determined 14 d postprimary NP-CGG immunization using ImageJ. Data are
pooled from three independent experiments. n = 13. ***p < 0.0001.
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PlxnD1−/− B cells participate in the GC reaction less efficiently than WT B cells. A,
Schematic of experimental design. B, Reduced frequency of PlxnD1−/−-derived GC B cells
relative to those with WT cells, as measured by flow cytometry. Mice were immunized (i.p.)
with NP-CGG in alum, and spleens were harvested at day 14 postimmunization. Percentage
of FO B cell reconstitution was determined by flow cytometry using anti-B220, CD45.1, and
CD45.2 Abs. The percentage of PlxnD1−/− CD45.2+B220highGL-7high B cells of total
B220high cells was determined by flow cytometry and was reduced relative to the percentage
of WT CD45.1+B220highGL-7high controls. n = 6 mice per group. Mean ± SEM are
presented for each genotype. Data were obtained in two separate experiments. C, Reduced
frequency of GC B cells in PlxnD1−/− (□) B cells relative to WT (■) B cells. Quantification
of GC B cells, as measured by flow cytometry. The graph is representative of two
independent experiments. Each point represents data from one mouse. p < 0.001. D, Splenic
sections from chimeric mice were stained with various combinations of CD45.1, CD45.2,
GL-7, and B220 Abs to determine the presence of WT and PlxnD1−/− B cells in the GCs (i).
Splenic sections from WT/PlxnD1−/− chimeric mice were stained with various combinations
of CD45.1, CD45.2, IgD, and CD21 Abs to determine the presence of WT and PlxnD1−/− B
cells in the GC light and dark zones (ii). Images were acquired using a Zeiss LSM 710
confocal immunofluorescent microscope. n = 6 mice per group.
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Impaired in vitro migration of activated PlxnD1−/− B cells, but normal GC B cell
proliferation and cell death. A, Purified WT (□) and PlxnD1−/− (■) FO B cells were
activated in vitro, placed in the same well, and subjected to competitive in vitro migration
assays in the presence of medium alone, CXCL12, CXCL13, and CCL19 (A). WT and
PlxnD1−/− B cells were differentiated by CD45.1 and CD45.2 expression. Migrated cells
were quantified by flow cytometry and are presented as percentage of total input cells. n =
6–7 mice per group. B, WT and PlxnD1−/− mice were immunized with NP-CGG. Ten days
postimmunization, mice were injected i.p. with BrdU (1 mg/ml in PBS) and sacrificed 5 h
later. Splenocytes were labeled with anti-IgM, IgD, B220, and BrdU Abs to distinguish GC
B cells. BrdU incorporation is expressed as percentage of total GC B cells. Data are
representative of four individual mice per group. C, Sections (5 μm) of spleens from WT
and PlxnD1−/− mice at day 14 postimmunization were labeled with IgD–PE (red) and
TUNEL (green) Abs. Images were acquired using a Zeiss Axiovert 200M confocal
immunofluorescent microscope. TUNEL+ cells were quantitated for individual mice and
pooled. n = 4 mice per group.
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Impaired secondary Td immune response in PlxnD1−/− mice. A and B, Serum Ig levels after
primary and secondary immunization in WT (solid line) and PlxnD1−/− (dotted line) mice.
Mice were immunized (i.p.) with NP18-CGG in alum and boosted at day 28 postprimary
immunization. Serum was harvested at various time points. Data were pooled from three
independent experiments. **p < 0.01 and n = 11 mice per group. C, The ratio of NP2/NP25
was estimated as an indicator of affinity maturation. D, Ag-specific splenic AFC formation
in mice reconstituted with WT (■) and PlxnD1−/− (□) fetal liver cells. Spleens were
harvested at day 5 and 14 postimmunization. NP-specific IgG AFC were enumerated by
ELISPOT. E, Ag-specific BM AFC formation in mice reconstituted with PlxnD1−/− and WT
fetal liver cells. BM was harvested at day 14 postsecondary immunization. NP-specific IgG
AFC were enumerated, as above. Data were pooled from three independent experiments.
Mean ± SEM. **p < 0.01 and n = 10 mice per group.
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